Verschraegen, C F <br/><br/>
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Oct 2003 
 - 549-55 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0171-5216 
<br/><br/><label>Standard No.: </label>10.1007/s00432-003-0481-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Area Under Curve<br/>Ascites--metabolism<br/>Carcinoma, Signet Ring Cell--drug therapy<br/>Colorectal Neoplasms--drug therapy<br/>Endometrial Stromal Tumors--drug therapy<br/>Female<br/>Humans<br/>Injections, Intraperitoneal<br/>Liposomes<br/>Male<br/>Mesothelioma--drug therapy<br/>Middle Aged<br/>Organoplatinum Compounds--administration & dosage<br/>Ovarian Neoplasms--drug therapy<br/>Peritoneal Neoplasms--drug therapy<br/>Peritoneum--diagnostic imaging<br/>Radionuclide Imaging<br/>Technetium<br/>Tissue Distribution